phase iii results of olaparib for brca breast cancer
Published 7 years ago • 598 plays • Length 2:19Download video MP4
Download video MP3
Similar videos
-
10:34
solo1: maintenance olaparib in advanced brca ovarian cancer
-
4:47
maintenance therapy with parp inhibitor olaparib delays progression in patients with brca-relate...
-
3:02
mediola: olaparib and durvalumab for germline brca-mutated metastatic breast cancer
-
3:26
different treatment strategies for brca positive breast cancer
-
2:57
olaparib and durvalumab in metastatic brca wild type triple-negative breast cancer
-
4:19
treating brca breast cancer with parp inhibition
-
4:14
olaparib continues to show positive results in advanced ovarian cancer - 7 year data
-
3:24
solo-1: olaparib or placebo for patients with newly diagnosed brca-mutated advanced ovarian cancer
-
8:09
olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...
-
2:59
parp inhibitor olaparib as treatment for pancreatic cancer patients with brca gene mutations
-
3:37
olaparib in metastatic pancreatic cancer, the polo trial
-
1:13
final os results from paola-1 evaluating 1l maintenance olaparib plus bevacizumab
-
1:10
dr. tripathy on impact of olaparib approval in brca-positive breast cancer
-
4:23
comment: parp inhibitor olaparib plus bevacizumab in women with ovarian cancer
-
2:03
polo trial: olaparib as a maintenance treatment following first-line chemotherapy in patients wi...
-
5:48
solo1: 7-year follow-up highlights the value of maintenance olaparib
-
4:47
phase iii study of veliparib with carboplatin and paclitaxel in her2-negative advanced/metastati...
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
1:32
parp inhibitor olaparib exceeds expectations in brca pancreatic cancer management